This guidance highlights the importance of continuing Parkinson’s disease (PD) medication and provides details of the location of PD medications across NHSGGC which can be accessed for immediate supply.
Parkinson’s Disease Medication Stocklist, Acute Hospitals (213)
exp date isn't null, but text field is
A guideline is intended to assist healthcare professionals in the choice of disease-specific treatments. Clinical judgement should be exercised on the applicability of any guideline, influenced by individual patient characteristics.
Clinicians should be mindful of the potential for harmful polypharmacy and increased susceptibility to adverse drug reactions in patients with multiple morbidities or frailty.
If, after discussion with the patient or carer, there are good reasons for not following a guideline, it is good practice to record these and communicate them to others involved in the care of the patient.
It is CRUCIAL NOT TO STOP PD DRUGS for any significant length of time ie > 2 hours or to miss any doses i.e. as there is a risk of Neuroleptic Malignant-Like Syndrome (Parkinson hyperpyrexia syndrome, PHS) which may be fatal. Symptoms include rigidity, pyrexia, and reduced conscious level. There may be features of autonomic instability, and serum creatine kinase (CK) may be elevated. Complications of PHS include acute renal failure, aspiration pneumonia, deep venous thrombosis / pulmonary embolism, and disseminated intravascular coagulation.
Where a patient does not have an individual supply of their PD medicine, access supplies via the pharmacy or the local main holding areas of PD medications across NHSGGC (see table 1). It is important for PD medications to be administered at exact times. This should be clearly annotated on the prescription chart.
PD drug |
NVH |
QEUH |
GRI |
GGH |
RAH |
IRH |
VoL |
Amantadine 100mg CAPs |
x |
55, EDC |
x |
x |
x |
x |
14 |
Amantadine 50mg/5ml liquid |
x |
55, EDC |
x |
x |
x |
x |
x |
Apomorphine 10mg/ml(5ml amp) |
x |
EDC |
EDC |
x |
3 |
x |
x |
Apomorphine pre-filled syringe 5mg/ml(10ml) |
x |
55, EDC |
EDC |
x |
3 |
EDC |
x |
Bromocriptine 2.5mg TABs |
x |
EDC |
x |
x |
x |
x |
14 |
Co-beneldopa 12.5/50 CAPs |
NVH1&2 |
67,55, EDC |
39 EDC |
EDC |
AMU, 3 |
GSouth, 2,3, EDC |
14 |
Co-beneldopa 12.5/50 DISP |
NVH1 |
67,55, EDC |
39 |
EDC |
3,36 |
2, EDC, J North |
14 |
Co-beneldopa 25/100 CAPs |
NVH2 |
67,55, EDC |
39 |
EDC |
3 |
2,3 |
14 |
Co-beneldopa 25/100 DISP |
NVH2 |
55 |
39 |
EDC |
3 |
2 |
14 |
Co-beneldopa 50/200 CAPs |
x |
55 |
x |
x |
x |
2 |
14 |
Co-beneldopa 25/100 mr CAPs |
NVH1&2 |
55, EDC |
39 |
x |
3 |
2 |
14 |
Co-careldopa 10/100 TABs |
x |
55 |
39 |
EDC |
x |
EDC |
14 |
Co-careldopa 12.5/50 TABs |
NVH1&2 |
67,55, EDC |
39 |
EDC |
3 |
GSouth,2, EDC |
14 |
Co-careldopa 25/100 TABs |
NVH1 &2 |
67,55, EDC |
39 |
EDC |
3 |
2,3 |
14 |
Co-careldopa 25/250 TABs |
x |
55,EDC |
39 |
x |
x |
EDC |
14 |
Co-careldopa 25/100 mr TABs |
NVH1&2 |
55, EDC |
39 |
x |
3 |
EDC |
14 |
Co-careldopa 50/200 mr TABs |
NVH1&2 |
55 |
x |
x |
3 |
x |
14 |
Entacapone 200mg TABs |
NVH1 |
55, EDC |
39 |
x |
3 |
EDC |
14 |
Pramipexole 88mcg TABs |
x |
55 |
39 |
x |
3 |
EDC, 2 |
14 |
Pramipexole 180 mcg TABs |
x |
55 |
39 |
x |
3 |
EDC |
14 |
Pramipexole 350 mcg TABs |
x |
EDC |
39 |
x |
x |
x |
x |
Pramipexole 700 mcg TABs |
x |
x |
x |
x |
3 |
EDC |
14 |
Pramipexole 1050 mcg mr TABs |
x |
55 |
x |
x |
x |
2 |
x |
Pramipexole 1570 mcg mr TABs |
x |
55 |
x |
x |
x |
2 |
x |
Pramipexole 2100mcg mr TABs |
x |
55 |
x |
x |
x |
2 |
x |
Pramipexole 2.62mg mr TABs |
x |
55, EDC |
x |
x |
x |
2 |
14 |
Rasagiline* 1mg TABs |
x |
55 |
39 |
x |
x |
x |
x |
Ropinirole 250 mcg TABs |
x |
55, EDC |
39 |
x |
x |
x |
14 |
Ropinirole 1mg TABs |
x |
EDC |
39 |
x |
3 |
EDC |
14 |
Ropinirole 2mg TABs |
x |
x |
x |
x |
3 |
2 |
14 |
Ropinirole 2mg m/r TABs |
x |
55, EDC |
39 |
x |
3 |
EDC, 2 |
14 |
Ropinirole 4mg m/r TABs |
x |
55 |
x |
x |
x |
2 |
14 |
Ropinirole 8mg m/r Tabs |
x |
55, EDC |
x |
x |
x |
2 |
14 |
Rotigotine 2mg/24 hr patch |
NVH1 |
55, EDC |
39 |
EDC |
3 |
EDC, 2, J North |
14 |
Rotigotine 4mg/24hr patch |
NVH1 |
55 |
39 |
EDC |
3 |
EDC, 2 |
14 |
Rotigotine 6mg/24hr patch |
x |
55 |
x |
x |
3 |
2 |
14 |
Rotigotine 8mg/24hr patch |
x |
55 |
x |
x |
3 |
2 |
x |
Selegiline 5mg TABs |
x |
55 |
39 |
x |
3 |
EDC |
14 |
Stanek 50/12.5/200 TABs |
x |
55, EDC |
39 |
EDC |
3 |
EDC, 2 |
14 |
Stanek 75/18.75/200 TABs |
x |
55, EDC |
39 |
EDC |
3 |
EDC, 2 |
14 |
Stanek 100/25/200 TABs |
x |
55, EDC |
39 |
EDC |
3 |
EDC, 2 |
14 |
Stanek 125/31.25/200 TABs |
x |
55, EDC |
39 |
EDC |
3 |
EDC, 2 |
14 |
Stanek 150/37.5/200 TABs |
x |
55, EDC |
39 |
EDC |
3 |
EDC |
14 |
Stanek 175/43.75/200 TABs |
x |
55 |
x |
x |
x |
EDC, 2 |
14 |
Stanek 200/50/200 TABs |
x |
55 |
39 |
x |
x |
EDC,2 |
14 |
- *Rasagiline is non-formulary, however it can be supplied to patients established on therapy. Request for new initiation would need to follow GGC non-formulary
- Duodopa intestinal gel – Patient’s own supply would need to be brought into hospital for
- x -not available on ward (contact pharmacy/on-call pharmacist for a supply)
NVH-New Victoria Hospital
QEUH-The Queen Elizabeth University Hospital
GRI-Glasgow Royal Infirmary
GGH-Gartnavel General Hospital
RAH-Royal Alexandra Hospital
IRH-Inverclyde Royal Hospital
VoL-Vale of Leven
EDC-Emergency Drug Cupboard
ARU-Acute Receiving Unit
AMU - Acute Medical unit
PLEASE NOTE: Further stock of PD medications is kept at pharmacies across NHSGGC sites. Contact pharmacy / on-call pharmacist for a supply.